Appropriate Systemic Therapy Dosing for Obese Adult Patients with Cancer
Publication Date: April 26, 2021
Key Points
Key Points
- The Panel continues to recommend that full, weight-based cytotoxic chemotherapy doses be used to treat obese adults with cancer.
- The Panel also recommends that full, approved doses of immunotherapy and targeted therapies be offered to obese adults with cancer.
- In the event of toxicity, the consensus of the Panel is that dose modifications of systemic antineoplastic therapies should be handled similarly for obese and non-obese patients.
Treatment
...Tre...
...ased dosing of cytotoxic chemotherapy shou...
...recommends limiting fixed dosing of chemotherapy...
...proved prescribing information for c...
...escribing information for targeted therapies shou...
...ient experiences high-grade toxicity...
...recommends that BSA be calculated using any of...